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Abstract
Background—Depression frequently co-occurs with cognitive decline, but the nature of this 
association is unclear. We examined relations of late-life depressive symptom patterns to 
subsequent domain-specific cognitive changes.
Methods—Depressive symptoms were measured at up to 3 timepoints among 11,675 Nurses’ 
Health Study participants prior to cognitive testing. Depressive symptom patterns were categorized 
as non-depressed, variable, or persistent, based on published severity cutpoints. Outcomes were 
global, verbal, and executive function-attention composite scores.
Results—Participants with persistent depressive symptoms had worse executive function-
attention decline compared to non-depressed participants (multivariable-adjusted mean 
difference=-0.03 units/year, 95% CI: −0.05, −0.01; p=0.003); this difference was comparable to 8 
years of aging. However, being in the persistent vs. non-depressed group was not significantly 
related to verbal (p=0.71) or global score (p=0.09) decline. By contrast, compared to the non-
depressed group, those with variable depressive symptoms had worse verbal memory decline 
(multivariable-adjusted mean difference=−0.01 units/year, 95% CI: −0.02, −0.002; p=0.03); this 
group showed no differences for global or executive function-attention decline.
Conclusions—A variable pattern of depressive symptom severity related to subsequent decline 
in verbal memory, while a persistent pattern related to decline in executive function-attention. 
Findings could signal differences in underlying neuropathologic processes among persons with 
differing depression patterns and late-life cognitive decline.
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1. INTRODUCTION
Depression and cognitive impairment, including dementia, frequently co-occur in older 
adults.(Zubenko et al., 2003, Olin et al., 2002) There are several possible explanations for 
this high degree of comorbidity. Late-life depression may be an independent risk factor for 
cognitive decline or may represent a prodromal phase of dementing illness.(Amieva et al., 
2008)
Conflicting evidence exists regarding the influence of depression on subsequent cognition 
and dementing illnesses. Some research indicates that depression may increase risk of 
cognitive decline. In one study, older adults with baseline depression showed greater 
hippocampal atrophy over follow-up and this reduction in volume was associated with worse 
cognitive-decline.(Steffens et al., 2011) Further, lifetime history of depression increases risk 
of dementia and recurrent depressive episodes monotonically increase this risk.(Van Duijn et 
al., 1994, Dotson et al., 2010)
Other studies provide evidence in favor of a prodromal contribution of depression to 
cognitive decline and dementia. A study of older twins (Steffens et al., 1997) found that 
history of a major depressive episode was associated with an increased risk of Alzheimer 
disease (AD). However, as the time between the onsets of the depressive episode and 
dementia increased, the risk of developing dementia decreased - indicating that these 
depressive symptoms may reflect prodromal AD. Additionally, in a study of hospitalized 
older adults with depression, those with co-morbid depression and dementia had a later age 
of first depression onset compared to those with depression alone.(Alexopoulos et al., 1993)
If late-life depression (LLD) is a prodromal indicator of underlying neuropathology, then 
differences in patterns of antecedent depressive symptoms may relate to different sub-types 
of cognitive decline (e.g., amnestic vs. dysexecutive). However, few studies(Paterniti et al., 
2002, Singh-Manoux et al., 2010, Kohler et al., 2010, Graziane et al., 2016) have examined 
how LDD patterns relate to subsequent cognitive decline by domain. In one example 
(Paterniti et al., 2002) cognitively normal older adults with persistent, but not variable, 
depressive symptoms showed greater cognitive decline compared to those with no 
depression; however, domain-specific associations were not examined. Domain-specific 
cognitive-functioning was examined (Singh-Manoux et al., 2010) among 4271 participants 
aged 35-55 years followed for 18 years: persistent depressive symptoms in late-midlife, 
compared to no symptoms, increased odds of worse cognitive function for all domains. 
However, cognition was assessed only at the end of follow-up, and information was 
unavailable regarding how depression patterns related prospectively to cognitive trajectories; 
furthermore, the young age of participants limited applicability to the question of how LLD 
patterns relate to subsequent cognition. In a study concurrently examining depression and 
cognition over 6 years (Kohler et al., 2010), older adults with persistently-high depressive 
symptoms showed worse decline in memory, processing-speed and global functioning, 
compared to those who never had high depressive symptoms. Another study (Graziane et al., 
2016) examined dual trajectories of depression and cognitive function simultaneously over 5 
years: worsening, low-grade depression was related to persistently low attention, while 
moderate depression was related to persistently low executive, language and memory. 
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However, the simultaneous assessment of depression and cognition in these studies limited 
the ability to relate LLD patterns to subsequent cognitive outcomes.
The field can benefit from studies addressing how patterns of LLD symptoms relate to 
subsequent cognitive change – both globally and within domains. Thus, we related patterns 
of LLD symptoms, measured up to 3 times over 8-years among 11,675 older women in the 
Nurses’ Health Study (NHS), to subsequent change in cognitive domains, serially assessed 
up to 4 times over an average of 5.5 years.
2. METHODS
2.1 Study sample
In 1976, 121,700 female nurses aged 30 to 55 years in 11 U.S. states were enrolled in the 
NHS. Participants have completed mailed questionnaires every two years since on lifestyle, 
behavioral and health-factors and medical-outcomes. Follow-up has remained at 
approximately 90%. In 1992, 1996 and 2000, participants completed the Mental Health 
Inventory–5 (MHI-5) sub-scale from the Medical Outcomes Study Short-form-36.(Ware and 
Sherbourne, 1992) Additionally, between 1995-2000 (Figure 1) those participants aged 70+ 
years without history of stroke were invited to enroll in a cognitive function sub-study. Of 
those invited to participate in this sub-study, 93% completed the initial interview. Three 
additional waves of cognitive follow-up have been completed.
The exposure is pattern of depressive symptoms, measured every 4 years by the MHI-5 
between 1992-2000. To be included in the analysis, participants must have completed at 
least two MHI-5 questionnaires prior to initial cognitive-testing. Of the initial cognitive sub-
study population of 19,415 women, 11,675 were included in our study due to exclusions for 
missing or insufficient depression questionnaire responses Cognitive sub-study participants 
excluded from the analysis had lower physical activity (15.0 vs 16.2 metabolic-equivalent 
task hours/week) and were more likely to be current smokers (10% vs 7%). They were 
comparable in age (74.3 vs 74.2 years) and proportion using antidepressants (5% vs 6%). 
Excluded participants also did not differ from those included in reported alcohol 
consumption, BMI or number of comorbidities. The Institutional Review Board of Brigham 
and Women's Hospital, Boston, MA, approved this study.
2.2 Ascertainment of depression
Depressive symptoms were measured using the MHI-5 contained within NHS questionnaire. 
The MHI-5 consists of five questions on frequency of symptoms (3 address depression, 2 
address anxiety) over the past four-week period, with six response options of: all, most, a 
good bit, some, a little, or none of the time.(Cuijpers et al., 2009) It has been validated for 
detection of depression.(Berwick et al., 1991, Rumpf et al., 2001, Friedman et al., 2005) 
MHI-5 scores range from 0 to 100, where lower scores indicate more severe symptoms. As 
done elsewhere, we used the cut-point of ≤52 to denote presence of severe depressive 
symptoms.(Holmes, 1998, Bultmann et al., 2006)
Since the objective was to relate LLD symptoms to subsequent cognitive decline, we only 
included MHI-5 responses prior to the start of cognitive testing. In our sample, 86% of 
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participants returned two questionnaires and 14% returned three questionnaires prior to 
initial cognitive interview. Depressive symptom patterns were categorized in three ways 
using the specified cut-point on the MHI-5: non-depressed, variable, and persistent.(Holmes, 
1998, Bultmann et al., 2006) If a participant reported MHI-5 scores >52 at all timepoints, 
she was assigned to the “non-depressed” group; if she scored ≤52 at all timepoints, she was 
assigned to the “persistent” group; finally, if she scored ≤52 at one or more timepoints, but 
not all, she was assigned to the “variable” group. The number of timepoints used to 
characterize pattern was based on entry date into the cognitive sub-study. For example, if a 
participant's initial cognitive interview occurred prior to the return of her 2000 NHS 
questionnaire, then only her 1992 and 1996 MHI-5 scores were used to categorize 
depressive symptoms; whereas if a participant's 2000 questionnaire was returned prior to her 
initial cognitive interview, then her 1992, 1996 and 2000 MHI-5 responses were used. The 
number of depression assessments completed prior to the initial cognitive testing differed 
between groups; two depression assessments were completed prior to the first wave of 
cognitive testing among 86%, 79%, and 93%, respectively, of the non-depressed, variable 
and persistent depression groups. However, the number of assessments used to categorize 
depression is expected to be unrelated to outcome; therefore, any bias related to these 
differences would be non-differential. In order to verify this, we conducted a sensitivity 
analysis in which we categorized the entire sample based only on the 1992 and 1996 
depression questionnaires and compared results to our main analyses.
2.3 Ascertainment of cognitive function
Cognitive function was assessed using a telephone-based method described elsewhere.
(Okereke and Grodstein, 2013, Stampfer et al., 2005) Briefly, beginning in 1995 participants 
were administered the Telephone Interview for Cognitive Status (TICS), assessing general 
cognition and comparable to the Mini-Mental State Examination.(Brandt J, 1988, Folstein et 
al., 1975) Participants were also administered other tests starting in 1997, including: 
immediate and delayed recall trials of the East Boston Memory Test (EBMT); category 
fluency test (number of animals named within 60 seconds); delayed-recall trial of a 10-word 
list; and digit-span backwards.(Brandt J, 1988, Albert et al., 1991) Initial cognitive 
assessments were completed between 1995-2001. The telephone-based assessment has 
excellent reliability and validity.(Stampfer et al., 2005)
Study outcomes were composite scores of global, verbal memory, and executive function/
attention. Based on means and standard deviations from the first cognitive wave, z-scores 
were calculated for each test. The global score was created by averaging z-scores of all 
cognitive tests. Verbal memory was calculated by averaging z-scores of 4 tests: the 
immediate and delayed recall of the EBMT and 10-word list. The executive function/
attention score was created by averaging z-scores of the category fluency and digit span 
backwards tests.(Hedden et al., 2012) Composite scores were only calculated if the 
participant had completed all component tests.
2.4 Statistical analysis
Cognitive outcomes were modeled continuously using SAS PROC MIXED (SAS v. 9.3, 
SAS Institute, USA). We used linear mixed-effects models with person-specific random-
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effects, where cognitive interview date was the time index. Basic models included time, age 
(years, continuous), education (RN, BA, or advanced) and the three depression pattern 
groups, as well as interactions of these terms with time. Multivariable model covariates were 
selected a priori based on prior literature and ascertained from the questionnaire returned 
immediately before initial cognitive testing. The multivariable-adjusted model included all 
terms from the basic model, plus the following covariates and their interactions with time: 
smoking (current, past, never), alcohol use (grams/day), body mass index (BMI) (kg/m2), 
and physical-activity (MET hrs/week). Finally, an expanded model added other covariates, 
including medical comorbidities that may represent either confounders or intermediates. 
This model included all covariates from the above multivariable model plus: cardiovascular 
disease (history of myocardial infarction and/or coronary artery bypass grafting); 
hypertension; dyslipidemia; history of cancer other than non-melanoma skin cancer; 
respiratory disease (asthma and/or chronic obstructive pulmonary disease); diabetes; and 
antidepressant use. Covariate data were obtained through self-report.
2.5 Secondary analyses
Because depression has been associated with increased attrition, we conducted a sensitivity 
analysis to address the potential for informative censoring. This was accomplished by 
repeating all models adjusting for censoring using stabilized inverse probability censoring 
weights (IPCW) and comparing to unweighted models. (Hernan et al., 2000, Robins, 1999, 
Robins et al., 2000) Further information on IPCW is available in the Supplemental Methods. 
Finally, in a supplementary analysis, we examined logistic regression models estimating the 
relation of depression pattern to likelihood of being in the worst 10% of change from the 
first to fourth cognitive interview. An advantage of this approach is to provide odds ratios 
that may be more interpretable in clinical literature. Logistic models were adjusted for all 
covariates in the expanded multivariable model, plus baseline composite score and timespan 
of follow-up; we again conducted sensitivity analyses using IPCW.
3. RESULTS
3.1 Participant Characteristics
Table 1 displays baseline characteristics by depression group. There were 10,723 women in 
the non-depressed group, 763 in the variable group and 189 in the persistent group. The non-
depressed group had lower BMI, higher physical activity, higher alcohol consumption, and 
lower prevalence of co-morbidities. Use of antidepressants among a small proportion of 
those classified as non-depressed may reflect presence of indications other than depression 
(e.g., neuropathic pain, insomnia, etc.), indicate maintenance treatment to sustain euthymic 
mood after previous depression, or signal that depression was present but not at the severity 
indicated by MHI-5≤52.
3.2 Multivariable Models
Multivariable-adjusted least-squares mean cognitive scores at baseline and over follow-up 
(Figure 2) indicated that the persistent group generally had the lowest scores in each of the 
cognitive domains, and the variable group had scores intermediate to the other categories. 
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However, divergence in the executive function/attention scores over follow-up was notable 
for the persistent vs. other groups.
Basic model results are presented in Model 1 of Table 2. In the main multivariable model 
(Model 2), adjusted for lifestyle factors, the persistent symptom group had significantly 
lower global (p=0.001) and verbal-memory scores (p<0.001) cross-sectionally, compared to 
the non-depressed group. No cross-sectional differences between the persistent and non-
depressed groups were observed for the executive-function/attention domain (p=0.52). The 
variable pattern group showed no statistically significant cross-sectional mean differences 
compared to non-depressed group. Results were similar after adjusting for co-morbidities 
and potential intermediates.
When examining cognitive change in the main model, the variable pattern group had 0.01 
standard units/year worse decline in verbal memory (95% CI: −0.02 to −0.001) compared to 
the non-depressed group (p=0.03). By contrast, no significant difference was observed in 
verbal memory change when comparing the persistent to non-depressed groups (p=0.71). 
Regarding executive function/attention domain, the opposite was observed: the persistent 
group had 0.03 standard units/year greater decline (95% CI: −0.05 to −0.01, p=0.003) 
compared to the non-depressed group; yet, no differences were seen for the variable group 
(p=0.95). The observed mean difference in cognitive decline in the executive-function/
attention domain for the persistently depressed group was comparable to that which would 
be observed for women 8 years apart in age. No statistically significant differences were 
observed for cognitive change in the global score comparing the no depression group to 
either the persistent (p=0.09) or the variable depression groups (p=0.11). Estimates after 
inclusion of co-morbidities and potential intermediates were generally similar to those from 
the main model.
3.3 Sensitivity Analyses
When categorizing the sample using only the 1992 and 1996 questionnaires, nearly identical 
point estimates were observed compared to the main analyses (data not shown in tables). We 
further considered the possibility that some individuals might be categorized as being in the 
variable pattern group based on differences in their MHI-5 scores of only a few points. We 
determined that only 43 participants were assigned to the variable-pattern based on 
variations of <5 points on MHI-5 scores. In a sensitivity analysis, we excluded these 43 
participants and reran the models; results were unchanged.
3.4 IPCW Sensitivity Analyses
Higher attrition was observed for those in the persistent and variable depressive symptom 
pattern groups compared to the non-depressed group (Supplemental Table 1). To account for 
possible informative-censoring, we performed sensitivity analyses using IPCW (Table 3). 
Point-estimates remained similar to those in the main analyses, although results for verbal 
memory change were attenuated (p=0.07) for the variable group. Findings of steeper decline 
in executive function/attention among the persistently depressed vs. non-depressed group 
were similar to main results.
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3.5 Logistic Models of Worst Cognitive Change
In logistic models of worst cognitive change (Supplemental Table 2), results were 
comparable to those observed when analyzing change continuously. For example, the 
persistent-depressive group had increased odds of worst cognitive change compared to the 
non-depressed group; however, no statistically significant associations were observed. 
Statistical power was lower in the logistic models than in linear models using continuous 
cognitive scores.
4. Discussion
In this study of patterns of LLD symptoms and cognition, a pattern of persistent severe 
symptoms was related to lower scores at all cognitive assessments. However, in analyses of 
cognitive change over time, the persistent and variable patterns of depressive symptoms 
related differently to decline in specific cognitive domains. Those persistently reporting 
severe depressive symptoms at all timepoints had significantly worse declines in executive 
function/attention, but not other cognitive domains, compared to those never reporting 
severe depressive symptoms. By contrast, those variably reporting severe depressive 
symptoms at some but not all timepoints had modest but statistically significant worse 
subsequent decline in verbal memory – but not in other domains – compared to those never 
reporting severe symptoms.
These results may have clinical relevance, as domain-specific differences in rates of 
cognitive change by depression pattern group may signal distinct underlying etiologies. In a 
2012 (Hedden et al., 2012) cross-sectional study of 168 cognitively normal adults (65-86 
years), amyloid-burden was associated with worse episodic-memory performance, while 
white-matter-hyperintensities (WMH) were associated most strongly with executive-
function deficits. High amyloid-burden is a hallmark of brain pathology in patients with AD, 
while high WMH burden is more typical in vascular dementia. Vascular dementia frequently 
presents with early executive dysfunction while deficits in verbal memory are more 
commonly seen early in AD.(Roman and Royall, 1999, Gomez and White, 2006) The 
presence of WMH has also been associated with LLD and the vascular depression 
hypothesis in which a constellation of vascular risk factors predisposes the brain to 
development of depression.(Taylor et al., 2013) Further, when LLD is accompanied by 
executive-function deficits, studies indicate especially poor response to antidepressant 
treatment.(Alexopoulos et al., 2005) Additionally, greater regional burden of WMH has been 
associated with worse response to antidepressant treatment.(Taylor et al., 2014) It may be 
that vascular pathology contributes both to a persistent pattern of LLD that is particularly 
resistant to treatment as well as to the executive dysfunction symptoms seen in vascular 
dementia. These findings hint towards the possibility that differing courses of depression and 
domain-specific cognitive declines may signal differences in underlying brain pathologies.
Our results are intriguing, in light of emerging hypotheses regarding the nature of 
neuropsychiatric symptoms preceding cognitive decline. Verbal (or episodic) memory 
decline relates closely to amnestic cognitive impairment and is a key predictor of AD.(Chen 
et al., 2001, Kang et al., 2006) It has been hypothesized that depressive symptoms may be 
part of the lengthy prodromal phase of AD.(Amieva et al., 2008) Our results suggest that a 
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temporal pattern of variable depressive symptoms, rather than persistently severe symptoms, 
is related specifically to subsequent episodic memory decline among older adults. If LLD 
were a risk factor for AD, we would expect that those with persistent severe depressive 
symptoms would have worse cognitive decline in verbal memory, which is most closely 
related to AD. Because only variable, not persistent, depressive symptoms were related to 
episodic memory decline, this may suggest that LLD in such cases represents a prodromal 
manifestation of underlying illness. Conversely, it is also possible that an unstable course of 
depressive symptoms is intrinsically more detrimental to verbal memory, and subsequent 
risk of AD, than a persistent severe course.
Our findings may have clinical implications. Poor executive function is associated with 
worse performance in activities of daily living.(Johnson et al., 2007) Thus, the significantly 
worse course of executive function observed among those with persistent depressive 
symptoms could signal future impairments that may adversely affect independence. 
Identification of LLD patterns may assist clinicians in monitoring for domain-specific 
cognitive changes and the associated potential hazards.
Strengths of this study include large sample size, prospective design, and well-validated 
questionnaire information over many years. Another advantage was the examination of how 
patterns of depressive symptoms measured at multiple timepoints related to subsequent 
trajectories within specific cognitive domains. Sensitivity analyses using IPCW to 
investigate the potential for informative censoring is another strength of our approach.
Study limitations are also important to consider. First, length of cognitive follow-up may 
have been insufficient to detect differences in the patterns of decline. However, the mean age 
at cognitive baseline for the cohort was approximately 74 years. Since older age is a known 
risk factor for cognitive-decline, an average follow-up of almost six years likely captures 
meaningful trajectories. Additionally, the observed longitudinal pattern of scores illustrates 
that change is occurring and is evident across the four timepoints. Second, depressive 
symptoms were categorized based on self-report from screening instruments rather than by 
gold-standard psychiatric diagnosis. However, use of such instruments provides an 
opportunity to capture depressive symptoms among those reluctant to seek treatment in a 
clinical setting. Third, misclassification of depression patterns is possible due to unobserved 
symptoms between questionnaire intervals. However, such misclassification is likely to be 
non-differential (i.e., unrelated to the outcome). Although not guaranteed to do so 
(Dosemeci et al., 1990), such misclassification would likely bias toward the null for effect 
estimates and, thus, would render our findings more conservative. Further, use of repeated 
measures to categorize depressive symptoms provides more opportunity to capture 
gradations of symptoms. Having additional depressive symptom assessments, beyond the 
2-3 timepoints included in this study, might have facilitated characterizing patterns with 
further granularity; however, we used a strictly-defined prospective approach of limiting 
depression assessments to those occurring prior to the start of cognitive testing. Fourth, 
although there is little reason to suspect that the relationship between LLD patterns and 
cognitive decline would differ among demographic groups, generalizability of our results 
may be a concern, given the small numbers of non-white participants and lack of male 
participants. Fifth, these highly educated nurses may have higher cognitive reserve than the 
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general population; this could limit generalizability of results. Finally, our study only 
examined how depression relates to performance on objective cognitive tests; these results 
do not show how antecedent depression patterns relate to structural or functional changes in 
the brain.
In conclusion, this study of nearly 12,000 older adults found that antecedent patterns of LLD 
symptoms were related differentially to subsequent decline in cognitive domains. The 
presence of persistently severe depressive symptoms was related to subsequent decline in the 
frontal-executive domain, but not episodic memory. On the other hand, a variable pattern of 
depressive-symptoms was related to later decline in episodic memory, but not executive 
function. Our finding of contrasting relations of antecedent patterns of LLD symptoms to 
declines in different cognitive domains may signal the presence of distinct underlying 
processes. Future studies should aim to replicate these findings and incorporate neural 
markers.
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Key points
• Findings indicate differences in declines in specific cognitive domains by 
antecedent depressive symptom patterns.
• Compared to those without depressive symptoms, those with persistent severe 
depressive symptoms had greater declines in the executive function/attention 
domain, while those with variably severe depressive symptoms had greater 
declines in the verbal memory domain.
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Figure 1. 
Timeline of Depressive Symptom Measures and Cognitive Assessments
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Figure 2. 
Multivariable Adjusted Mean Cognitive Scores Over Time by Depressive-Symptom 
Category Global
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Table 1
Participant Characteristics by Depression Group
Characteristic* No Depression Variable Depression Persistent** Depression P-value
n=10723 n=763 n=189
Age, mean (sd) 74.2 (2.4) 74.1 (2.3) 74.1 (2.3) 0.57
Race 0.34
White, % 98% 99% 99%
Black, % 1% 0% 1%
Other, % 1% 1% 0%
Highest Attained Education 0.06
RN, % 77% 80% 84%
BA, % 17% 15% 12%
MA/Doctoral, % 7% 5% 4%
BMI, mean (sd) 26.0 (4.8) 26.1 (5.4) 26.9 (5.6) 0.02
Physical activity score, mean(sd) 16.5 (19.9) 12.4 (15.7) 11.0 (15.1) <0.0001
Mediterranean Diet Score, mean (sd) 4.4 (1.5) 4.2 (1.5) 4.1 (1.5) <0.0001
Hypertension, % 55% 61% 61% <0.003
High Cholesterol, % 67% 72% 77% <0.0001
Smoking Status 0.003
Never, % 47% 43% 39%
Past, % 46% 47% 48%
Current, % 7% 9% 13%
Alcohol use, mean (sd) 4.8 (9.1) 4.5 (9.8) 3.7 (8.3) 0.22
Hormone Use 0.02
Never, % 29% 26% 25%
Past, % 30% 32% 32%
Current, % 33% 35% 29%
Multi-vitamin use, % 63% 68% 66% 0.09
Antidepressant use, % 5% 17% 30% <0.0001
Cancer, % 19% 23% 21% 0.05
CVD†, % 10% 13% 16% <0.0001
Diabetes, % 10% 13% 18% <0.0001
Respiratory Disease‡, % 15% 20% 31% <0.0001
*
Information on baseline characteristics was obtained via self-reports by participants on NHS questionnaires
**No depression – no severe depressive symptoms reported at any baseline time points as determined by a Mental Health Inventory–5 score >52; 
Variable depression – severe depressive symptoms at some but not all baseline time points; Persistent depression – severe depressive symptoms 
reported at all baseline time points
†CVD includes myocardial infarction, coronary artery bypass grafting, or stroke
‡
Respiratory illness includes asthma or Chronic Obstructive Pulmonary Disease (COPD)
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